Figure 2From: Hand-foot syndrome associated with use of sorafenib in a patient with papillary thyroid cancer: a case report Hand-foot syndrome on the soles (A) and palms (B) (7 days after suspension of sorafenib and start symptomatic treatment). Back to article page